Journal profile · BIOCHEMISTRY & MOLECULAR BIOLOGY
Journal of Medical Biochemistry
ISSN 1452-8258 · eISSN 1452-8266 · Society of Medical Biochemists of Serbia · SERBIA · Quarterly · Founded 2007
Journal of Medical Biochemistry: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.74; fully open access; APC charged, amount not published; median 36 days to acceptance (200 articles, last 24 months); community-reported acceptance: easy; 307 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Medical Biochemistry is published by Society of Medical Biochemists of Serbia and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Clinical Laboratory Practices and Quality Control, Inflammatory Biomarkers in Disease Prognosis and Adipokines, Inflammation, and Metabolic Diseases, together about 25.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal publishes original scientific and specialized articles on all aspects of clinical and medical biochemistry, molecular medicine, clinical hematology and coagulation, clinical immunology and autoimmunity, clinical genomics and molecular biology, genetic epidemiology, drug measurement, evaluation of diagnostic markers, new reagents and laboratory equipment, reference materials and methods, reference values, laboratory organization, automation, quality control, clinical metrology, and all related scientific disciplines where chemistry, biochemistry, molecular biology, and immunochemistry deal with the study of normal and pathologic processes in human beings. All manuscripts are reviewed and, after final decision, are classified in the following catgories: a) oppinion papers, b) review articles, c) original papers, d) professional papers, e) preliminary reports, and f) letter to editor. There are also different reoprts and news, book reviews, reports on the activity of the Society of Medical Biochemists of Serbia and IFCC, and other organizations, and information about innovations, new reagents and instruments in the field of clinical chemistry.
From the journal's Aims & Scope
Research area (LetPub): BIOCHEMISTRY & MOLECULAR BIOLOGY
Editor-in-chief Nada Majkić-SinghPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Clinical Laboratory Practices and Quality ControlMedicine10.3%
- Inflammatory Biomarkers in Disease PrognosisMedicine8%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine7.4%
- Vitamin D Research StudiesMedicine5.7%
- Sepsis Diagnosis and TreatmentMedicine4.9%
- Inflammation biomarkers and pathwaysImmunology and Microbiology4.6%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine4.1%
- Thyroid Disorders and TreatmentsMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPubMedEmbaseCAB AbstractsPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, Crossref, SCIndeks, EuroPub, CABS, Sherpa/RoMEO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.74LetPub ·
- Impact factor (publisher)
- 1.5Publisher website ·
- 5-year impact factor (publisher)
- 1.8Publisher website ·
- CiteScore 2026-06
- 1.8LetPub ·
- SJR 2026-06
- 0.42LetPub ·
- SNIP 2026-06
- 0.71LetPub ·
- h-index
- 14LetPub ·
- h-index
- 38OpenAlex ·
- i10-index
- 308OpenAlex ·
- 2-year mean citedness
- 0.5OpenAlex ·
- Self-citation rate
- 31.6%LetPub ·
- Share of gold OA articles
- 98.93%LetPub ·
Volume
- Articles per year
- 213LetPub ·
Articles by year OpenAlex count · 1,392 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 153 | 153 | 0 |
| 2025 | 307 | 307 | 128 |
| 2024 | 84 | 84 | 145 |
| 2023 | 77 | 77 | 392 |
| 2022 | 65 | 65 | 386 |
| 2021 | 48 | 48 | 430 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
36 daysMedian, submission to acceptance · P25–P75 30 days – 44 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 200 articles with submission and acceptance dates (377 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | RSD 141,000 / EUR 1,200 | No | CC BY | |
| OpenAlex | RSD 58,000 | — | — | |
| LetPub | EUR 1,200 / RSD 141,000 | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- letter to editorf) letter to editorLength not stated
- oppinion papersa) oppinion papersLength not stated
- original papersc) original papersLength not stated
- preliminary reportse) preliminary reportsLength not stated
- professional papersd) professional papersLength not stated
- review articlesb) review articlesLength not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Society of Medical Biochemists of Serbia
- Country or region
- SERBIA
- Language
- Serbian, English
- Frequency
- Quarterly
- Founded
- 2007
- ISSN
- 1452-8258
- Electronic ISSN
- 1452-8266
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Medical Biochemistry
What CAS zone is Journal of Medical Biochemistry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Medical Biochemistry is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Medical Biochemistry?
The latest impact factor listed by LetPub is 1.74; CiteScore 1.8, h-index 38.
How long does peer review take at Journal of Medical Biochemistry?
Based on the dates recorded on 200 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 36 days (interquartile range 30–44 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Medical Biochemistry?
According to LetPub and DOAJ records, Journal of Medical Biochemistry is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, PMC, PubMed, Embase and CAB Abstracts; that list has not been checked against each database.
Is Journal of Medical Biochemistry open access, and what is the APC?
Journal of Medical Biochemistry is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .